Sirozlu hastada HBsAg/Anti-HBs serokonversiyonu

Basit Öğe Kaydı
dc.contributor.authorGülhan M.
dc.contributor.authorTopuz M.F.
dc.contributor.authorYildiz-Gülhan P.
dc.contributor.authorÖztürk O.
dc.contributor.authorGül S.
dc.date.accessioned2020-06-25T15:17:54Z
dc.date.available2020-06-25T15:17:54Z
dc.date.issued2017
dc.departmentKırıkkale Üniversitesi
dc.description.abstractChronic hepatitis B infection can lead to serious and mortal illnesses such as cirrhosis and hepatocellular carcinoma. HBsAg usually persists in chronic Hepatitis B patients. Spontaneous or being treated Anti-HBs seroconversion can be rarely observed and considered to be the endpoint of treatment if he is being trated. In this case study, it is mentioned that 63 years old patient who does not know that he has cirrhosis but Anti-HBs positive. The patient applied to our clinic to take some regular follow-ups which have not been taken for many years. In his first examination it was learned that the patient has been hepatises positive for 20 years and stopped follow-ups after taking two years medical treatment. The patient's whose physical examination is normal and it was detected that Anti-HBs pozitive and thrombocytopenia in blood tests. It was show that abdominal ultrasonography findings conform with cirrhosis. When it was investigated patient's earlier results with Anti-HBs positive to search in terms of cirrhosis etiology, his previous biopsy was reported as cirrhosis 19 years ago. The causes cirrhosis is hepatitis be HBsAg /Anti-HBs seroconversion developed after cirrhosis. The tenofovir treatment was started to patient who has low titer HBV DNA and treated with interferon previously. The Anti-HBs positivity can detract the specialists from hepatitis B infection when cirrhosis etiology is investigatedin patients. The patient whose previous anamnesis was not detailed can be misdiagnosis. HBVDNA test should considered when the cirrhosis etiology is investigated in Anti-HBs positive patient with cirrhosis. It was presented this case because there is no HBsAg/Anti-HBs seroconversion after cirrhosis published before.en_US
dc.identifier.doi10.5505/TurkHijyen.2017.25932
dc.identifier.endpage346en_US
dc.identifier.issn03779777
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85038121071
dc.identifier.scopusqualityQ4
dc.identifier.startpage341en_US
dc.identifier.trdizinid266215
dc.identifier.urihttps://doi.org/10.5505/TurkHijyen.2017.25932
dc.identifier.urihttps://hdl.handle.net/20.500.12587/2567
dc.identifier.volume74en_US
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isotr
dc.publisherRefik Saydam National Public Health Agency (RSNPHA)en_US
dc.relation.ispartofTurk Hijyen ve Deneysel Biyoloji Dergisi
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAnti-HBs seroconversionen_US
dc.subjectCirrhosisen_US
dc.subjectHepatitis Ben_US
dc.titleSirozlu hastada HBsAg/Anti-HBs serokonversiyonuen_US
dc.title.alternativeHBsAg/Anti-HBs seroconversion in cirrhotic patienten_US
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu